About

Michael Weiss is an Executive Managing Director with Cushman & Wakefield specializing in life sciences real estate, GMP manufacturing site selection, tenant representation, portfolio management, and strategic consulting. Since joining the firm in 2013, he has advised biotechnology, pharmaceutical, medical device, and advanced manufacturing companies on complex real estate and location strategies across the United States and internationally. As a leader within the firm's GMP manufacturing site selection practice, Michael helps organizations evaluate markets, identify optimal locations, and develop real estate strategies that support growth, innovation, and operational performance.

Michael is recognized for his expertise in biologics, radiopharmaceuticals, cell and gene therapy, antibody-drug conjugate (ADC), and other advanced manufacturing environments. His experience spans cross-border transactions, state and local incentives negotiations, labor and market assessments, and facility strategy for highly specialized GMP operations. By combining deep life sciences real estate knowledge with an understanding of manufacturing and business requirements, Michael helps clients make informed location decisions, mitigate risk, and align their real estate strategy with long-term corporate objectives.

Clients

• West Pharma
• Resmed
• Legend Biotech
• Genmab
• ICU Medical
• Advancell 
• Lonza 
• Cooper Companies
• Atara Bio
• Bavarian Nordic
• Wuxi Apptec 
• Brown & Brown Insurance

Areas of Specialization

• Life Sciences Real Estate
• Global Portfolio Management 
• GMP Manufacturing 
• Global Site Selection

Community Involvement

• Bottom Line Organization 
• Spoonfuls 
• American Heart Association 

Education

• University of Massachusetts Amherst, BA